Menu

Genetics Paper Retracted

Due to statistical errors, a Science paper claiming that mutation is responsible for genetic variation is retracted.

Sep 2, 2011
Jessica P. Johnson

cow-pea weevilWIKIMEDIA COMMONS, MAGNUS MANSKE

A May 2010 Science paper showing that the most genetically fit cow-pea weevils have fewer deleterious genetic mutations in their genomes than their less fit counterparts was retracted yesterday (September 1) by the authors because of flaws in their statistical analysis.

The results seemed to answer a long-standing question of how genetic variation can persist in a population even though individuals are under constant pressure from natural and sexual selection to weed out deleterious mutations, according to a news report from the University of Zurich in Switzerland. The researchers contended that their results offered further support of the hypothesis that genetic mutations are constantly appearing in populations, and that individuals with the fewest bad mutations will produce the most fit offspring.

The statistical analysis that led to the conclusions was flawed because the authors failed to acknowledge that predicted weevil offspring phenotypes and observed offspring phenotypes are not independent variables. A technical comment that details the specific flaws was published alongside the retraction. The authors realized the error and when they reanalyzed their data, they “found a similar, but weaker, overall effect,” they wrote in the retraction. “Because the published correlation values are in error, we retract our original Report.”  The revised data analysis, which shows little effect on fitness due to mutation, suggests that some other mechanism may instead be responsible for maintaining genetic variation in weevil populations.

 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.